• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑人胎儿血红蛋白遗传性持续存在的一种新形式及其与镰状细胞性状的关联。

A new form of hereditary persistence of fetal hemoglobin in blacks and its association with sickle cell trait.

作者信息

Stamatoyannopoulos G, Wood W G, Papayannopoulou T, Nute P E

出版信息

Blood. 1975 Nov;46(5):683-92.

PMID:1174703
Abstract

A new form of hereditary persistence of fetal hemoglobin (HPFH) producing 3%-8% Hb F in heterozygotes and an elevation of F-cell counts as measured by both the Kleihauer test and an antibody fluorescent procedure was found during the study of a black family. Individuals with this anomaly also had sickle cell trait. A sickle cell homozygote who had apparently inherited the HPFH determinant had 20.3% Hb F. Both types of gamma-chains were present in equal proportions in the Hb F of these individuals. A population study revealed other AS individuals with increased Hb F synthesis, three of whom were sibs. The presence of this previously unrecognized form of HPFH might explain the mild clinical manifestations and the hemoglobin phenotypes of sickle cell homozygotes with unusual elevations of Hb F.

摘要

在对一个黑人家庭的研究中,发现了一种新形式的遗传性胎儿血红蛋白持续存在(HPFH),杂合子中产生3%-8%的Hb F,通过Kleihauer试验和抗体荧光法测量,F细胞计数升高。具有这种异常的个体也有镰状细胞性状。一名显然遗传了HPFH决定因素的镰状细胞纯合子有20.3%的Hb F。在这些个体的Hb F中,两种类型的γ链比例相等。一项群体研究发现了其他Hb F合成增加的AS个体,其中三人是同胞。这种先前未被认识的HPFH形式的存在可能解释了Hb F异常升高的镰状细胞纯合子的轻度临床表现和血红蛋白表型。

相似文献

1
A new form of hereditary persistence of fetal hemoglobin in blacks and its association with sickle cell trait.黑人胎儿血红蛋白遗传性持续存在的一种新形式及其与镰状细胞性状的关联。
Blood. 1975 Nov;46(5):683-92.
2
The synthesis of fetal hemoglobin types in red blood cells and in BFU-E derived colonies from peripheral blood of patients with sickle cell anemia, beta+ - and delta beta-thalassemia, various forms of hereditary persistence of fetal hemoglobin, normal adults and newborn.镰状细胞贫血、β+和δβ地中海贫血患者、各种形式胎儿血红蛋白遗传性持续存在患者、正常成年人及新生儿外周血红细胞和BFU-E衍生集落中胎儿血红蛋白类型的合成。
Hemoglobin. 1979;3(4):223-52. doi: 10.3109/03630267908996900.
3
[Hereditary persistence of fetal Hb and its association with Hb S. 1st case found in Costa Rica].[胎儿血红蛋白的遗传性持续存在及其与血红蛋白S的关联。在哥斯达黎加发现的首例病例]
Sangre (Barc). 1989 Oct;34(5):371-4.
4
Homozygotes for the hereditary persistence of fetal hemoglobin: the ratio of G gamma to A gamma chains and biosynthetic studies.胎儿血红蛋白遗传性持续存在的纯合子:Gγ与Aγ链的比例及生物合成研究
Biochem Genet. 1977 Dec;15(11-12):1083-96. doi: 10.1007/BF00484499.
5
beta Thalassemia associated with increased HB F production. Evidence for the existence of a heterocellular hereditary persistence of fetal hemoglobin (HPFH) determinant linked to beta thalassemia in a southern Italian population.与血红蛋白F(HB F)生成增加相关的β地中海贫血。在意大利南部人群中存在与β地中海贫血相关的胎儿血红蛋白(HPFH)决定簇异细胞遗传性持续存在的证据。
Hemoglobin. 1981;5(1):1-17. doi: 10.3109/03630268108996907.
6
The distribution of fetal hemoglobin and the types of gamma chain in red cell fractions separated by gradient centrifugation from blood of patients with sickle cell anemia and other hemoglobinopathies.镰状细胞贫血及其他血红蛋白病患者血液经梯度离心分离的红细胞组分中胎儿血红蛋白的分布及γ链类型。
Biochem Med. 1983 Jun;29(3):337-54. doi: 10.1016/0006-2944(83)90069-8.
7
Occurrence of G gamma Hb F in Greek HPFH: analysis of heterozygotes and compound heterozygotes with beta thalassaemia.希腊遗传性胎儿血红蛋白持续存在症中Gγ血红蛋白F的出现:β地中海贫血杂合子和复合杂合子的分析
Br J Haematol. 1979 Dec;43(4):521-36. doi: 10.1111/j.1365-2141.1979.tb03785.x.
8
Adult and fetal hemoglobin production in erythroid colonies from subjects with beta-thalassemia or with hereditary persistance of fetal hemoglobin (HPFH).β地中海贫血或胎儿血红蛋白遗传性持续存在(HPFH)患者红系集落中成人血红蛋白和胎儿血红蛋白的生成。
Hemoglobin. 1980;4(3-4):449-67. doi: 10.3109/03630268008996226.
9
Variations in globin chain synthesis in hereditary persistence of fetal haemoglobin.胎儿血红蛋白遗传性持续存在时珠蛋白链合成的变化
Br J Haematol. 1976 Mar;32(3):357-64. doi: 10.1111/j.1365-2141.1976.tb00939.x.
10
F-cells in the adult: normal values and levels in individuals with hereditary and acquired elevations of Hb F.成人中的F细胞:遗传性和获得性Hb F升高个体的正常值及水平
Blood. 1975 Nov;46(5):671-82.

引用本文的文献

1
Regenerative Medicine: Case Study for Understanding and Anticipating Emerging Science and Technology.再生医学:理解和预测新兴科学技术的案例研究。
NAM Perspect. 2023 Nov 15;2023. doi: 10.31478/202311d. eCollection 2023.
2
Base editors dissect genetic variants in human hematopoietic cells on a large scale.碱基编辑器大规模解析人类造血细胞中的遗传变异。
Trends Immunol. 2023 Jul;44(7):490-492. doi: 10.1016/j.it.2023.05.009. Epub 2023 Jun 12.
3
In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies.
经静脉注射单次载体即可实现体内碱基编辑,用于治疗血红蛋白病。
JCI Insight. 2022 Oct 10;7(19):e162939. doi: 10.1172/jci.insight.162939.
4
Activation of γ-globin gene expression by GATA1 and NF-Y in hereditary persistence of fetal hemoglobin.GATA1 和 NF-Y 激活 γ-珠蛋白基因表达导致遗传性胎儿血红蛋白持续存在。
Nat Genet. 2021 Aug;53(8):1177-1186. doi: 10.1038/s41588-021-00904-0. Epub 2021 Aug 2.
5
In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model.体内造血干细胞基因治疗使用双模块 HDAd5/35++ 载体治愈镰状细胞病小鼠模型。
Mol Ther. 2021 Feb 3;29(2):822-837. doi: 10.1016/j.ymthe.2020.09.001. Epub 2020 Sep 5.
6
Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies.基因组编辑策略在β-地中海贫血症中诱导胎儿血红蛋白。
Hum Mol Genet. 2020 Sep 30;29(R1):R100-R106. doi: 10.1093/hmg/ddaa088.
7
Angelicin-A Furocoumarin Compound With Vast Biological Potential.当归素——一种具有巨大生物潜力的呋喃香豆素化合物。
Front Pharmacol. 2020 Apr 16;11:366. doi: 10.3389/fphar.2020.00366. eCollection 2020.
8
A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease.一项评估 voxeloTOR 在镰状细胞病患者中的 1/2 期递增剂量和开放标签扩展研究。
Blood. 2019 Apr 25;133(17):1865-1875. doi: 10.1182/blood-2018-08-868893. Epub 2019 Jan 17.
9
Gene therapy for sickle cell disease: An update.镰状细胞病的基因治疗:最新进展。
Cytotherapy. 2018 Jul;20(7):899-910. doi: 10.1016/j.jcyt.2018.04.003. Epub 2018 May 30.
10
Hydroxyurea in Sickle Cell Disease: Our Experience in Western India.羟基脲治疗镰状细胞病:我们在印度西部的经验。
Indian J Hematol Blood Transfus. 2016 Jun;32(2):215-20. doi: 10.1007/s12288-015-0542-1. Epub 2015 May 16.